Analysts Issue Forecasts for ACHC FY2024 Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – KeyCorp issued their FY2024 earnings per share estimates for Acadia Healthcare in a report issued on Monday, January 6th. KeyCorp analyst M. Gillmor expects that the company will post earnings of $3.39 per share for the year. KeyCorp currently has a “Overweight” rating and a $70.00 target price on the stock. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. KeyCorp also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.73 EPS, Q1 2025 earnings at $0.66 EPS, Q4 2025 earnings at $0.77 EPS, FY2025 earnings at $3.20 EPS and FY2026 earnings at $3.98 EPS.

Other equities analysts also recently issued research reports about the company. TD Cowen lowered their price target on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research report on Tuesday. Cantor Fitzgerald reissued a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Royal Bank of Canada reissued an “outperform” rating and set a $64.00 price target on shares of Acadia Healthcare in a research report on Friday. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and upped their target price for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. Finally, StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $70.22.

Acadia Healthcare Price Performance

NASDAQ:ACHC opened at $44.92 on Thursday. The stock’s 50-day simple moving average is $40.48 and its 200 day simple moving average is $58.19. The company has a market cap of $4.17 billion, a P/E ratio of 14.73, a P/E/G ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.91 earnings per share.

Institutional Investors Weigh In On Acadia Healthcare

Several institutional investors have recently made changes to their positions in ACHC. Point72 Asset Management L.P. boosted its stake in shares of Acadia Healthcare by 266.0% in the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock valued at $153,339,000 after buying an additional 1,650,040 shares during the period. Wellington Management Group LLP boosted its stake in shares of Acadia Healthcare by 12.2% in the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after buying an additional 1,266,384 shares during the period. Millennium Management LLC boosted its stake in shares of Acadia Healthcare by 3,067.8% in the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock valued at $73,640,000 after buying an additional 1,055,894 shares during the period. Holocene Advisors LP boosted its stake in shares of Acadia Healthcare by 201.5% in the third quarter. Holocene Advisors LP now owns 972,513 shares of the company’s stock valued at $61,667,000 after buying an additional 649,997 shares during the period. Finally, William Blair Investment Management LLC boosted its stake in shares of Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after buying an additional 604,070 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.